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The organizational action of testosterone during critical periods of development is the cause
of numerous sex differences in the brain. However, sex differences in neuritogenesis have
been detected in primary neuronal hypothalamic cultures prepared before the peak of
testosterone production by fetal testis. In the present study we assessed the hypothesis of
that cell-autonomous action of sex chromosomes can differentially regulate the expression
of the neuritogenic gene neurogenin 3 (Ngn3) in male and female hypothalamic neurons,
generating sex differences in neuronal development. Neuronal cultureswere prepared from
male and female E14 mouse hypothalami, before the fetal peak of testosterone. Female
neurons showed enhanced neuritogenesis and higher expression of Ngn3 than male
neurons.The silencing of Ngn3 abolished sex differences in neuritogenesis, decreasing the
differentiation of female neurons.The sex difference in Ngn3 expressionwas determined by
sex chromosomes, as demonstrated using the four core genotypesmousemodel, in which
a spontaneous deletion of the testis-determining gene Sry from the Y chromosome was
combined with the insertion of the Sry gene onto an autosome. In addition, the expression
of Ngn3, which is also known to mediate the neuritogenic actions of estradiol, was
increased in the cultures treated with the hormone, but only in those from male embryos.
Furthermore, the hormone reversed the sex differences in neuritogenesis promoting
the differentiation of male neurons. These ﬁndings indicate that Ngn3 mediates both
cell-autonomous actions of sex chromosomes and hormonal effects on neuritogenesis.
Keywords: Ngn3, sex differences, sex chromosomes, estradiol, neuritogenesis, hypothalamic neurons
INTRODUCTION
Since the pioneering work of Phoenix et al. (1959), showing that
testosterone during the fetal period masculinizes and defeminizes
sex behavior in the female guinea pig, numerous laboratories have
identiﬁed the organizational action of testosterone during critical
periods of development as the main cause of the generation of sex
differences in the brain (Arnold and Gorski, 1984). This action
of testosterone is in part mediated by its local conversion into
estradiol by the enzyme aromatase (MacLusky andNaftolin,1981).
The developmental actions of estradiol in the brain have been well
characterized, especially in the hypothalamus where the hormone
regulates neuritogenesis and generates sex differences in neuronal
circuits controlling neuroendocrine events, feeding, growth, and
reproduction (Ferreira and Caceres, 1991; Díaz et al., 1992; Lenz
and McCarthy, 2010; Semaan and Kauffman, 2010).
Not all sex differences in the nervous system can be attributed
to the actions of gonadal hormones. For instance, sex differences
have been detected in the development of neurons and glial cells
in mesencephalic and hypothalamic cultures obtained from rat
and mouse embryos at embryonic day 14 (E14; Engele et al., 1989;
Reisert et al., 1989; Beyer et al., 1990, 1992; Reisert and Pilgrim,
1991) and E16 (Cambiasso et al., 1995, 2000), respectively. These
sex differences cannot be attributed to the peakof testosteronepro-
duction by fetal testis, which in mice is at E17-18 (O’Shaughnessy
et al., 1998, 2006) and in rats at E18.5-19.5 (Huhtaniemi, 1994;
Scott et al., 2009). However, it is not possible to completely exclude
any effect of hormones derived from the gonads at or before the
embryonic age used.
Recent studies have explored whether cell-autonomous actions
of sex chromosomes (i.e., actions that are not mediated by
the hormones produced by the gonads) are involved in the
generation of sex differences in the nervous system. This has
been facilitated by the development of the four core geno-
types mouse model, in which a spontaneous deletion of the
testis-determining gene Sry from the Y chromosome (Y−) was
combined with the insertion of the Sry gene onto an autosome
(Lovell-Badge and Robertson, 1990; Mahadevaiah et al., 1998).
Mating XY−Sry males to XX females produces four type of
progeny: XX females, XY− females, XXSry males and XY−Sry
males. These males are masculinized equivalently by testosterone
secretions during development, and thus differ phenotypically
from both female groups (De Vries et al., 2002; Arnold and
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Burgoyne, 2004; Arnold and Chen, 2009). Cell-autonomous
actions of sex chromosomes on sex differences in the number of
dopaminergic neurons in primary mesencephalic cultures (Car-
ruth et al., 2002), in the density of vasopressin immunoreactive
ﬁbers in the lateral septum (De Vries et al., 2002), in nocicep-
tion (Gioiosa et al., 2008), in some aspects of social behavior
(Gatewood et al., 2006), in habit formation (Quinn et al., 2007),
in motor deﬁcits in experimental autoimmune encephalomyeli-
tis (Smith-Bouvier et al., 2008), in Ang II-bradycardic baroreﬂex
response (Caeiro et al., 2011), and in sodium depletion-induced
brain activity (Dadam et al., 2014) have been identiﬁed using this
model.
In the present study we have tested the hypothesis of cell-
autonomous sex-biasing action of X and Y genes (Davies et al.,
2006; Arnold and Chen, 2009; Kopsida et al., 2009; Arnold et al.,
2013) can differentially regulate the expression of neuritogenic
genes in male and female hypothalamic neurons, generating
sex differences in neuronal development. In particular, we have
focused on the autosomal gene neurogenin 3 (Ngn3; MGI:893591;
located in chromosome 10 in mouse and humans), which is a gene
required for the correct speciﬁcation of neuronal subtypes con-
trolling energy homeostasis in the ventromedial hypothalamus
(Pelling et al., 2011) and has recently been implicated in neuri-
togenesis (Salama-Cohen et al., 2006; Simon-Areces et al., 2010).
In addition, recent studies have shown that Ngn3 expression is
upregulated by estradiol in hippocampal neurons (Ruiz-Palmero
et al., 2011). Since during the critical period of hormonal-induced
brain sexdifferentiation estradiol, produced in themale brain from
peripheral testosterone, is involved in the generation of sex differ-
ences in hypothalamic neurons (Matsumoto and Arai, 1986), we
have also investigated the effect of the hormone on neuritogenesis
and Ngn3 expression.
Our ﬁndings indicate that the differential expression of Ngn3
in male and female neurons, which is regulated by sex chromo-
somes, is involved in the generation of sex differences in the rate
of neuronal differentiation. In addition, estradiol enhances the
differentiation of male neurons through increasing Ngn3 levels,
abolishing sex differences in neuronal development. These ﬁnd-
ings indicate that sex chromosomes regulate sex differences in
the rate of hypothalamic neuronal development by an interaction
of direct cell autonomous actions and indirect actions medi-
ated by gonadal hormones. Therefore, the process of neuronal
sex differentiation seems to be more complex than previously
thought.
MATERIALS AND METHODS
ANIMALS
The embryos used for this study were obtained from CD1 mice
raised in the Cajal Institute (Madrid, Spain) and MF1 four core
genotypes (FCG) mice born and reared in the Ferreyra Institute
(Córdoba, Argentina). The day of vaginal plug was deﬁned as
E0. All procedures for handling and killing the animals used in
this study were in accordance with the European Commission
guidelines (86/609/CEE and 2010/63/UE) and the Spanish Gov-
ernment Directive (R.D. 1201/2005). Experimental procedures
were approved by the Cajal Institute Ethic Committee of Animal
Experimentation.
The FCG mouse model combines a deletion of the testis-
determining gene Sry from the Y chromosome (Y−) with the
subsequent insertion of a Sry transgene onto an autosome (Lovell-
Badge and Robertson, 1990; Mahadevaiah et al., 1998). The Sry
gene deletion in XY mice (XY−) yields in a female phenotype
(ovaries). When the Sry transgene is inserted into an autosome
of these mice they have testes and are fully fertile (XY−Sry).
Male and female are deﬁned here according to the gonadal phe-
notype. The Y− chromosome and the Sry transgene segregates
independently, thus, four types of offspring are produced by
breeding XY−Sry males to XX females: XX and XY− females
(without Sry on the Y chromosome) and XXSry and XY−Sry
male mice (both with Sry in an autosome). By comparing these
genotypes, it is feasible to segregate the role of (a) sex chromo-
some complement (comparing mice with the same gonadal type
but with different sex chromosomes: XX vs. XY) (b) gonadal
phenotype (males vs. females regardless of the sex chromosome
complement) and (c) their interaction (Arnold and Chen, 2009).
Throughout the text, we will refer to XX and XY− as XX and
XY females, and to XXSry and XY−Sry as XX and XY male mice,
respectively.
HYPOTHALAMIC NEURONAL CULTURES AND CELL TREATMENTS
Hypothalamic neurons were obtained from embryonic day 14
(E14) mouse embryos. Cells were cultured separately accord-
ing to the sex and/or genotype of fetal donors. Male fetuses
were identiﬁed under a dissecting microscope by the presence
of the spermatic artery on the developing gonad. The brain was
dissected out and the meninges were removed. Then, the ven-
tromedial hypothalamic region, delimited by the optic chiasm,
the lateral hypothalamic sulcus and the mammillary bodies, was
dissected out from the diencephalon. The blocks of tissue were
dissociated to single cells after digestion for 15 min at 37◦C with
0.5% trypsin (Worthington Biochemicals, Freehold, NJ,USA) and
DNase I (Sigma—Aldrich Co., St. Louis,MO,USA) and washed in
Ca2+/Mg2+-freeHank’s Buffered Salt Solution. Neuronswere cul-
tured in phenol red-free Neurobasal supplemented with B-27 and
GlutaMAX I (Invitrogen, Crewe,UK). Formorphometric analysis,
cells were plated on glass coverslips at a density of 150 cells/mm2
and maintained in vitro for 1–7 days. Some cultures were treated
for 4 days in vitro (DIV) with 17β-estradiol (10−10 M; Sigma-
Aldrich) or vehicle. For gene expression analyses, cells were plated
on 6-wells plates at a density of 800 neurons/mm2 and after 3 DIV
the medium was replaced for 2 h by fresh medium devoid of
B27 and GlutaMAX I supplement. Then, some cultures were
incubated for 2 hwith 17β-estradiol (10−10 M) or vehicle. The sur-
faces of glass coverslips and plates were coated with poly-L-lysine
(Sigma-Aldrich).
GENOTYPING
Genotyping of FCG was performed on genomic DNA samples
of E14 mouse embryos by PCR for the Sry transgene [primers
SryF (forward): CTA CAC AGA GAG AAA TAC CCA AAC; SryR
(reverse): GTC TTG CCT GTA TGT GAT GG] (Gubbay et al.,
1990) and the Y long-arm gene family Ssty [primers SstyF (for-
ward): CTG GAG CTC TAC AGT GAT GA; SstyR (reverse):
CAG TTA CCA ATC AAC ACA TCA C] (Turner et al., 2000).
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The autosomal gene myogenin [primers MYOF (forward): TTA
CGT CCA TCG TGG ACA GCA T; MYOR (reverse): TGG GCT
GGG TGT TAG TCT TAT] served as an ampliﬁcation control
(Palaszynski et al., 2005) yielding a 245-bp product in all geno-
types. Ampliﬁcation of DNA yielded the following products
according to the genotypes: for XY males the 159-bp Sry and the
302-bp Ssty; for XY females the 302-bp Ssty; for XX males the
159-bp Sry; meanwhile in XX females only the myogenin control
product was ampliﬁed.
INHIBITION OF Ngn3 EXPRESSION USING SMALL INTERFERING RNAs
Small interfering RNA (siRNA) oligonucleotides were pur-
chased from Applied Biosystems (Weiterstadt, Germany)/Ambion
(Austin, TX, USA) and the concentration was 25 nM during
transfection. A siRNA targeting Ngn3 (sense, AACUACAU-
CUGGGCACUGAtt; antisense, UCAGUGCCCAGAUGUAGU-
Ugt) and a control non-targeting siRNA were used. The efﬁcacy of
these siRNAs was previously demonstrated (Ruiz-Palmero et al.,
2011). For morphological analysis neurons were co-transfected at
3 DIV with pEGFP-C2 (Clontech, USA) plus one of the siRNA
oligonucleotides, using the Effectene Transfection Reagent (Qia-
gen GmbH, Hilden, Germany), following the manufacturer’s
instructions. After 16 h of treatment the cultures were pro-
cessed for immunostaining. The transfection efﬁciency was 0.1%.
Transfected neurons were recognized by EGFP expression. For
biochemical analysis, the same plasmids and siRNAs were nucleo-
fected into cultured neurons using anAmaxa nucleofectorwith the
Mouse Neurone Kit (Amaxa, Gaithersburg, MD, USA) in accor-
dance with the manufacturer’s instructions. After 1 DIV, neurons
were harvested and processed for real time PCR analysis. The
transfection efﬁciency with this method was 90%. For data repre-
sentation, we did not take in consideration the 10% of cells that
were not nucleofected.
ANALYSIS OF GENE EXPRESSION BY QUANTITATIVE REAL-TIME
POLYMERASE CHAIN REACTION (q-PCR)
Total RNAwas extracted from cultures with illustra RNAspinMini
RNA isolation kit from GE Healthcare (Buckinghamshire, UK).
RNA was eluted in 100 μl of RNase-free water and absorbance was
measured at 260 nm to determine concentrations. cDNA was syn-
thesized from 2 μg of total RNA by using the First Strand cDNA
Synthesis Kit from Fermentas GMBH (St Leon-Rot, Germany)
following the manufacturer’s instructions. Quantitative real-time
PCR was performed using the ABI Prism 7000 Sequence Detector
(Applied Biosystems, Weiterstadt, Germany), with conventional
AB cycling parameters (40 cycles of 95◦C, 15 s; 60◦C, 1 min).
TaqMan probes and primers for Ngn3 and for the control house-
keeping gene, Gapdh, were Assay-on-Demand gene expression
products (Applied Biosystems). Real-time PCRs were performed
following the suppliers instructions using the TaqMan PCR Mas-
ter Mix. All reactions were done in triplicates, from six different
cultures. Ngn3 expression was normalized for Gapdh expression.
To determine the effect of the experimental treatments on the
expression of the internal control gene, the relative amounts of
Gapdh were calculated using 2−T equation where CT = CT
treated – CT control (Livak and Schmittgen, 2001). No signiﬁcant
relationships were found between the treatments and expression
of Gapdh (p > 0.05) in any of the experiments done. Relative
mRNA expression level was calculated using the CT method.
IMMUNOCYTOCHEMISTRY
After 1–7 DIV or after treatment with siRNAs, cells were ﬁxed
for 20 min at room temperature in 4% paraformaldehyde and
permeabilized for 4 min with 0.12% Triton-X plus 0.12% gelatin
in phosphate buffered saline (PBS). Cells were then washed with
PBS/gelatin and incubated for 1 h with anti-microtubule associ-
ated protein-2 (MAP-2) mouse polyclonal antibody (diluted 1:250
in PBS/gelatin; Sigma-Aldrich), with anti-Tau rabbit monoclonal
antibody (diluted 1:250 in PBS/gelatin; Abcam, Cambridge, UK)
or with goat anti-green ﬂuorescent protein (GFP; diluted 1:1000
in PBS/gelatin; Abcam). Secondary antibodies wereAlexa 594 goat
anti-mouse, for the detection of MAP-2,Alexa 488 goat anti-rabbit
(1:1000), for the detection of Tau and Alexa 488-donkey anti-goat
(diluted 1:500; Molecular Probes), for the detection of GFP. Cell
nuclei were stained with DAPI.
MORPHOMETRIC ANALYSIS
After plating, dissociated neurons undergo several intermediate
stages of development (Dotti et al., 1988). The maturation of
hypothalamic neurons in cultures can be divided in ﬁve mor-
phological stages (Díaz et al., 1992). In stage I cells have a motile
lamellipodia around the periphery and neurites are not still
emerged (Figure 1A). After few hours, in stage II, the lamellipodia
condenses at several discrete sites where short neurites or minor
processes appear (Figure 1B). Stage III is characterized by the
formation and growth of the axon, which is a thin, long, and
Tau-positive neurite, relatively uniform in diameter (Figure 1C).
At this stage the neuron turn out to be polarized. Over time, the
remainingminor processes begin to elongate, but at amuch slower
rate than the axon, and acquire the tapering and Y angles branch-
ing, characteristic of dendrites at stage IV (Figure 1D). Further
progress, at stage V, includes the maturation of the axonal and
dendritic arbor, and the development of synaptic contacts and
dendritic spines. Under our culture conditions, at 7 DIV, all neu-
rons were at stage III or stage IV. Stage V was not observed. In
this study we evaluated the proportion of neurons in stages I, II,
III, and IV of differentiation from 1 to 7 DIV. In addition, we
assessed the number of primary neurites per neuron; the length
of minor processes, dendrites, and axon and the proportion of
cells with branched neurites. Dendrites were identiﬁed as MAP-
2 immunoreactive neurites with ramiﬁcations in Y angles with
shorter, straight segments. The axon was identiﬁed as one thin
neurite, longer than the others, which is immunoreactive for Tau
and not for MAP-2.
The morphometric analysis of immunostained neuronal cul-
tures was performed on digitalized images using the ImageJ 1.38
(NIH). Images were acquired through standard epiﬂuorescence in
a Leica microscope equipped with a Leica digital camera (Leica,
Heidelberg, Germany) at 20× or 40×magniﬁcations. Images were
coded, and the person conducting the analysis was blind to the
experimental group. For each sex, time in vitro and treatment, 60–
80 immunostained neurons that could be identiﬁed as individual
cells were analyzed; at least four separate cultures were made in
each condition.
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FIGURE 1 | Representative examples of primary hypothalamic neurons
at different stages of development. (A) Stage I; (B) Stage II; (C) Stage III
and (D), Stage IV. In stage I neurites are not still emerged. Neurons in
stage II show short neurites or minor processes. In stage III neurons show
a thin, long andTau-positive neurite, relatively uniform in diameter, which
corresponds to the axon. In stage IV dendrites showY angles branching.
Scale bar, 10 μm.
STATISTICAL ANALYSIS
Data are expressed by position parameters as media, median,
percentiles, and dispersion parameters as SEM and mini-
mum/maximum values. Kruskall Wallis or Mann Whitney-U
non-parametric tests for unpaired samples were used to compare
the number of neurons (median). According to data distribution,
one-way or two-way ANOVA followed by comparison of means
by Fisher’s least signiﬁcance difference (LSD) post hoc was used
as parametric test. A level of p < 0.05 was considered as statisti-
cally signiﬁcant. The n for statistical analysis was the number of
independent cultures.
RESULTS
SEX DIFFERENCES IN THE MORPHOLOGICAL STAGES OF MATURATION
To identify sex differences in neuronal development independent
of gonadal hormones, hypothalamic neuronal cultures were pre-
pared from male and female E14 mouse embryos, before the
peak of testosterone production by fetal testis, which in mice is
at E17-18 (O’Shaughnessy et al., 1998, 2006). We analyzed the
number of neurons at different stages of maturation from 1 to
7 DIV in sexually segregated cultures (Figures 2 and 3A). The
proportion of cells in early stages of differentiation (I, II) pro-
gressively decreased with time in culture, as the proportion of
cells in more differentiated stages (III, IV) increased. At 1 DIV
neurons were either in morphological stage I or in the morpho-
logical stage II of development (Figure 3A). Most neurons derived
from male remained at the morphological stage I of develop-
ment compared with female cultures (p = 0.008). In contrast,
the majority of the neurons derived from female embryos were
already in stage II (p = 0.008). At 2 DIV cells were in stages
I, II, or III of development (Figures 2A,B and 3A). The median
number of cells in stage I was still higher in male cultures com-
pared to female cultures (p = 0.032), although male and female
cultures reached a similar proportion of neurons in stage II. In
addition, only some female neurons had clearly differentiated their
axons and were, therefore, in stage III of development (sex dif-
ference, p = 0.008). At 3 DIV cells were in stages I, II, III, or
IV (Figure 3A). No cells in stage I were detected in female cul-
tures at 3 DIV (sex difference, p = 0.047). In addition, female
cultures showed a signiﬁcant decrease in the number of cells at
stage II compared to male cultures (p = 0.024) and a signiﬁcant
increase in the number of cells at stages III (p = 0.016) and IV
(p = 0.008) compared to male cultures. At 4 DIV cells in stage
I of development were no longer observed: cells were in stages
II, III, or IV (Figures 2C,D and 3A). The proportion of female
cells at stage II was signiﬁcantly decreased compared to male cul-
tures (p = 0.008). In contrast, the proportion of cells at stages III
(p = 0.015) and IV (p = 0.008) was higher in female cultures. At
5 DIV neurons were in stages II, III, and IV (Figure 3A). Male
and female cultures showed similar proportions of cells at stage
II. However, female cultures had a reduced proportion of cells at
stage III (p = 0.008) and an increased proportion of cells at stage
IV compared to male cultures (p = 0.008). At 6 DIV neurons were
in stages II, III, or IV (Figures 2E,F and 3A). Male and female
cultures showed a similar number of cells in stage II and in stage
III. However, female cultures showed a signiﬁcant increase in the
number of cells at stage IV compared to male cultures (p = 0.047).
By 7 DIV, cells in male and female cultures were at stages III or
IV, with similar number of the cells in each stage for both sexes
(Figure 3A).
Taken altogether these results indicate that the dynamic of neu-
ronal maturation is different in male and female hypothalamic
cultures: female neurons differentiated faster thanmale neurons in
culture until 6–7 DIV when neurons of both sexes acquire the fully
differentiated appearance characterized by the common features
of dendrites and axons.
SEX DIFFERENCES IN NEURITE OUTGROWTH
To further obtain detailed information about the described sex
differences in neuronal maturation we analyzed different mor-
phological parameters of cellular shape in hypothalamic neurons
maintained in culture from 1 to 7 DIV. There were no sex dif-
ferences in the mean number of primary neurites, whereas there
were an effect of time in vitro (main effect DIV: F6,51 = 24.61,
p < 0.001) as the number of primary neurites increased up to
3 DIV and remained stable thereafter (Table 1). The statistical
analysis of the length of minor processes (Table 1) and the length
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FIGURE 2 | Representative examples of hypothalamic neurons from male and female embryos at different days in vitro (DIV). (A) 2 DIV, male; (B) 2
DIV, female; (C) 4 DIV, male; (D) 4 DIV, female; (E) 6 DIV, male; (F) 6 DIV, female. Scale bar, 20 μm.
of dendrites (Table 1) indicated a signiﬁcant effect due to sex
(F1,52 = 8.58, p = 0.005 and F1,38 = 4.34, p = 0.044, respectively)
and DIV (F6,52 = 63.43, p < 0.001, and F1,4 = 36.19, p < 0.001,
respectively), showing a progressive increase in neuritic length in
both male and female cultures with time in vitro. Regarding to
the length of axons a signiﬁcant effect due to sex (F1,44 = 878.68,
p < 0.001), DIV (F5,44 = 1140.17, p < 0.001) as well as a sig-
niﬁcant interaction of sex and DIV (F5,44 = 611.77, p < 0.001)
were found. Fisher post hoc analysis revealed that at 2 DIV only
female neurons had already extended an axon and, day-by-day
comparison, revealed that female neurons showed longer axons
than male neurons from 3 to 5 DIV (p < 0.05, Figure 3B). More-
over, the proportion of neurons with branched neurites was also
different in male and female cultures. As shown in Figure 3C,
female cultures had signiﬁcantly higher median number of neu-
rons with branched neurites than male cultures from 1 to 5 DIV
(p ≤ 0.050).
Ngn3 WAS DIFFERENTIALLY EXPRESSED IN MALE AND FEMALE
HYPOTHALAMIC NEURONS
Since the transcription factor Ngn3 has been recently involved
in the control of neuritogenesis (Salama-Cohen et al., 2006;
Ruiz-Palmero et al., 2011), we assessed the expression of Ngn3
in sexually segregated hypothalamic cultures at 3 DIV. The
ANOVA analysis revealed a signiﬁcant effect of sex (F1,14 = 22.34,
p < 0.001) in the expression of Ngn3: female cultures showed sig-
niﬁcantly higher Ngn3 mRNA levels compared to male cultures
(p < 0.001, Figure 4A).
SEX DIFFERENCES IN Ngn3 EXPRESSION IN PRIMARY HYPOTHALAMIC
NEURONS WERE DETERMINED BY SEX CHROMOSOMES
We used the FCG mouse model to determine whether the sex
difference in Ngn3 expression in hypothalamic neurons was deter-
mined by any sex difference in levels of hormones derived from the
gonads at or before E14. Therefore, we analyzed Ngn3 mRNA lev-
els in cultures from XY male/XY female and XX male/XX female
mice. Two-way ANOVA revealed no effect of gonadal sex but a
signiﬁcant effect of sex chromosome complement (F1,28 = 12.60,
p < 0.001). Neurons carrying the XY chromosomes showed lower
expression levels of Ngn3 than neurons carrying XX chromo-
somes (p < 0.001), independently of having been originated
from gonadal male or gonadal female embryos (Figure 4B).
There was no interaction of gonadal sex and chromosome
complement.
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FIGURE 3 | Changes over time in morphological parameters of
hypothalamic neurons in sexually segregated cultures maintained
from 1–7 days in vitro (DIV). (A) Median number of neurons at different
stage of maturation: I, II, III, and IV (for references see caption in
Figure 1) (B) Mean of axonal length. (C) Median number of neurons with
branched neurites. Data are expressed as median or mean ± SEM.
n = 5–6 independent cultures for each sex. *p < 0.050, **p < 0.010, and
***p < 0.001.
Table 1 | Number of primary neurites, length of minor processes and length of dendrites in hypothalamic neuronal cultures of male (M) and
female (F) embryos.
Sex DIV
1 2 3 4 5 6 7
Primary neurites (number) M 1.3 ± 0.1a 1.5 ± 0.2b 2.5 ± 0.3c 2.7 ± 0.2c 2.2 ± 0.1c 2.1 ± 0.1c 2.2 ± 0.1c
F 1.3 ± 0.1a 1.7 ± 0.2b 2.6 ± 0.2c 2.7 ± 0.1c 2.6 ± 0.2c 2.5 ± 0.1c 2.3 ± 0.1c
Minor processes (μm) M 14.0 ± 1.2a 18.8 ± 1.6b 28.5 ± 2.6c 31.5 ± 2.3c 39.8 ± 3.4d 47.4 ± 2.3d 62.3 ± 3.9e
F 17.8 ± 1.5f 23.3 ± 3.3g 32.8 ± 2.9h 38.8 ± 2.7h 43.8 ± 4.0i 50.3 ± 3.7i 63.2 ± 2.2j
Dendrites (μm) M Absent Absent 78.4 ± 2.5a 94.5 ± 4.2b 105 ± 4.7c 121.2 ± 11d 141.4 ± 16d
F Absent Absent 82.8 ± 3.7e 103.2 ± 6.9f 118.4 ± 6.7g 138.3 ± 22h 134.8 ± 13h
Data represent the mean ± SEM. n = 4–6 independent cultures for each sex. Different letters indicate statistical differences between groups (p < 0.05).
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FIGURE 4 | Sex differences in the expression of Ngn3 in primary
hypothalamic neurons. (A) Ngn3 mRNA levels in male and female
hypothalamic neurons at 3 DIV. (B) Ngn3 mRNA levels in the four core
genotype model. (C) Validation of siRNA targeting Ngn3 (siRNA) and a
control non-targeting siRNA (nsRNA) in male and female hypothalamic
cultures. Data are mean ± SEM. n = 6–9 independent cultures for each sex
and treatment. LSD test indicated signiﬁcant differences ***p < 0.001.
DOWN-REGULATION OF Ngn3 EXPRESSION ABOLISHED SEX
DIFFERENCES IN MATURATION AND NEURITIC GROWTH OF
HYPOTHALAMIC NEURONS
In order to determine whether the observed sex differences inmat-
uration and neuritic growth of hypothalamic neurons depend on
the differential Ngn3 expression, we used siRNA strategy to reduce
Ngn3 levels. The electroporation delivery of siRNA targetingNgn3
resulted in a signiﬁcant decrease inNgn3mRNA levels inmale and
female cultures (F1,8 = 502.52, p < 0.001, Figure 4C).
Figure 5 shows the effects of siRNA targetingNgn3 on themor-
phology of hypothalamic neurons of male (Figures 5A,C,E–G)
and female embryos (Figures 5B,D,E–G). Sex differences observed
in neuronal differentiation and neuritogenesis under basal con-
ditions were still detected in the cultures transfected with the
non-target siRNA (nsRNA). Thus, male cultures treated with
the nsRNA showed a signiﬁcantly higher proportion of cells
at stage II of differentiation compared to female cultures (sex
difference, p = 0.027). In contrast, female cultures showed a
higher proportion of neurons at stage IV (p = 0.013) of mat-
uration (Figure 5E). In addition, male neurons showed shorter
axons compared to female neurons (p = 0.042; Figure 5F) and
male cultures showed a decreased proportion of neurons with
branched neurites than female cultures (p = 0.029; Figure 5G).
The transfection of siRNA targeting Ngn3 abolished these sex
differences, increasing the proportion of female cells at stage
II of maturation (p = 0.027; Figure 5E), decreasing the pro-
portion of female cells at stage IV of maturation (p = 0.013;
Figure 5E), decreasing the length of axons in female neurons
(p = 0.024; Figure 5F) and decreasing the proportion of neu-
rons with branched neurites in female cultures (p = 0.029;
Figure 5G).
In contrast, the Ngn3 siRNA did not have signiﬁcant effects in
the morphology of male neurons (Figures 5E–G). The length of
minor processes and the length of dendrites were not signiﬁcantly
affected by the transfection of siRNA targeting Ngn3, neither in
male nor in female cultures (Table 2). The ﬁnal outcome was that
the sex differences in the proportion of cells at different stages of
maturation, in axonal length and in neuritic branching, observed
under basal conditions, were abolished by the treatment with the
Ngn3 siRNA.
ESTRADIOL INCREASED Ngn3 mRNA LEVELS IN MALE, BUT NOT
FEMALE, NEURONS
Some cultureswere incubated for 2 hwith 17β-estradiol (10−10 M)
or vehicle and the levels of Ngn3 mRNA were evaluated. Two-
way ANOVA reveled a signiﬁcant interaction of sex and estradiol
treatment (F1,22 = 17.02; p < 0.001). The treatment with estra-
diol resulted in a signiﬁcant increase in the expression of Ngn3
in male cultures (p < 0.001, Figure 6A). Estradiol treatment
did not signiﬁcantly affect Ngn3 mRNA levels in female cultures
(p = 0.115). Thus, the effect of estradiol in male hypothalamic
neurons abolished the sex difference inNgn3:male cultures treated
with estradiol showed similar expression levels of Ngn3 mRNA
than female cultures under basal conditions.
ESTRADIOL ABOLISHED THE SEX DIFFERENCES IN MATURATION AND
AXONAL GROWTH OF HYPOTHALAMIC NEURONS
To determine the effect of estradiol on cell morphology, male
and female cultures were treated for 4 DIV with the hormone
or vehicle. Estradiol promoted the differentiation of male neu-
rons, reducing the proportion of cells in stage II (p = 0.008) and
increasing the proportion of cells in stages III (p = 0.012) and IV
(p = 0.009; Figure 6B). In contrast, estradiol did not signiﬁcantly
affect this parameter in female cultures. The effect of estradiol
on male cells resulted in the abolishment of the sex differences in
neuronal maturation: male cultures treated with estradiol showed
similar proportion of cells at the different stages of development
than female cultures under basal conditions or after estradiol
treatment.
Frontiers in Cellular Neuroscience www.frontiersin.org July 2014 | Volume 8 | Article 188 | 7
Scerbo et al. Ngn3-induced sex differences in the hypothalamus
FIGURE 5 | Down-regulation of Ngn3 expression abolished sex
differences in maturation and neuritic growth of hypothalamic
neurons. Neurons were co-transfected with the Ngn3 siRNAs and
pEGFP-C2 at 3 DIV and processed for immunostaining 16 h latter.
(A,B) Representative example of male (A) and female (B) neurons treated
with non-targeting siRNA. (C,D) Representative example of male (C) and
female (D) neurons treated with the Ngn3 siRNA. Scale bar, 10 μm.
(E) Effect of Ngn3 siRNA on the median number of primary hypothalamic
neurons at different stages of development. (F) Effect of Ngn3 siRNA on
the mean of axonal length. (G) Effect of Ngn3 siRNA on the median
number of neurons with branched neurites. Data are expressed as
median or mean ± SEM. n = 4–6 independent cultures for each sex and
treatment. Different letters indicate statistical differences between groups
(p < 0.05).
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Table 2 | Length of minor processes and length of dendrites in male
(M) and female (F) hypothalamic neuronal cultures transfected with
siRNA targeting Ngn3 (siRNA) or a control non-sense oligonucleotide
(nsRNA).
Sex Treatment
nsRNA siRNA
Minor processes (μm) M 34.9 ± 4.0 34.9 ± 3.6
F 46.7 ± 4.3 36.0 ± 1.9
Dendrites (μm) M 97.8 ± 10.4 107.9 ± 12.0
F 115.6 ± 9.6 116.5 ± 9.9
Data represent the mean ± SEM. n = 4–6 independent cultures for each sex.
The analysis of the effect of estradiol treatment on axonal
length showed a signiﬁcant effect of the hormone (F1,14 = 39.89;
p < 0.001) as well as a signiﬁcant interaction of sex with treatment
(F1,14 = 21.35; p < 0.001). Estradiol treatment increased axonal
length in male neurons (p < 0.001, Figure 6C). In contrast, estra-
diol did not signiﬁcantly affect this parameter in female neurons.
The ﬁnal result was that estradiol treatment reversed the sex differ-
ence in axonal length observed under basal conditions. Thus,male
neurons treated with estradiol showed longer axons than female
neurons under basal conditions (p = 0.007).
Estradiol treatment also increased the median number of
neurons with branched neurites in male cultures (p = 0.015,
Figure 6D). In contrast, estradiol did not signiﬁcantly affect this
parameter in female neurons. The ﬁnal result was that estradiol
treatment reversed the sex difference in the proportion of neurons
with branched neurites.
DISCUSSION
These results conﬁrmand extent our previous data on the existence
of sex differences in the growth and differentiation of hypothala-
mic neurons before the critical period of brain masculinization.
We now also show a sex difference in the expression of the neuri-
togenic transcription factor Ngn3 that is necessary for the greater
development in female cultures. Further, we demonstrate that the
sex complement determines the sexually dimorphic expression of
Ngn3 since XY vs. XX difference was found irrespective of the
gonadal type. These results additionally indicate that E2 added to
the culture media abolish all sex difference in the growth and dif-
ferentiation of hypothalamic neurons at this early developmental
age.
Hypothalamic neurons in culture show a progressive transition
for different differentiation stages (Díaz et al., 1992), which are
similar to those observed in primary hippocampal neurons (Dotti
et al., 1988). The proportion of cells in early stages of differen-
tiation (I, II) progressively decreased with time in culture, as the
FIGURE 6 | Effect of 17β-estradiol on Ngn3 mRNA levels and on
parameters of neuronal morphology after 4 DIV. (A) Ngn3 mRNA levels.
(B) Number of primary hypothalamic neurons at different stages of
development. (C) Mean of axonal length. (D) Median number of neurons
with branched neurites. Data are expressed as median or mean ± SEM.
n = 4–5 independent cultures for each sex and treatment. Different letters
indicate statistical differences between groups (p < 0.05), **p < 0.010,
***p < 0.001.
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proportion of cells inmore differentiated stages (III, IV) increased.
The increase in neuronal differentiation with time in culture was
accompanied by a progressive increase in the proportion of neu-
rons with branched neurites and by a progressive increase in the
length dendrites and axons.
Male and female neurons showed a different rate of differ-
entiation with time in culture. Thus, at 1 DIV, 18% of male
neurons showed neurites (Stage II), while 48% of female neu-
rons had already reach this stage. In addition, the proportion of
neurons with branched neurites at 1 DIV was higher in female
cultures. A similar situation was observed at 2, 3, 4, and 5 DIV,
where female neurons showed an enhanced morphological dif-
ferentiation compared to male neurons. For instance, by 2 DIV,
14% of female neurons were in stage III (polarized neurons),
while male neurons had not yet developed an axon. In addi-
tion, by 2 DIV, female cultures showed a higher proportion of
cells with branched neurites than male cultures. Sex differences
in the proportion of neurons at different stages of differentiation
were maintained until 4 DIV and sex differences in the proportion
of neurons with branched neurites were still observed a 5 DIV.
However, by 6 DIV, male and female cultures showed a similar
proportion of neurons in stages II, III, and IV and by 7 DIV, all
male and female neurons were at stages III and IV, with a simi-
lar proportion of cells in each stage in both sexes. These ﬁndings
suggest that female hypothalamic primary neurons differentiated
earlier than male neurons in culture. However, at the end, by
6–7 DIV, male and female neurons reached the same degree of
differentiation, indicating that the difference was in the speed of
the process and not in the ﬁnal outcome. Similar ﬁndings have
been obtained in rat mesencephalic cultures, where the outgrowth
of tyrosine hydroxylase-immunoreactive processes initially pro-
ceeded at a faster rate in female than in male cultures (Reisert
et al., 1989). The biological meaning of transient sex differences
in neuronal development is unknown. However, such differences,
in vivo, could allow the establishment of a sex dimorphic pattern
of synaptic connectivity by coordinating the development of pre
and postsynaptic structures. According to our ﬁndings, female
neurons would show a higher number of postsynaptic sites avail-
able when early synaptic afferents arrive and could then, by this
mechanism, establish a different pattern of synaptic connectivity
than male neurons.
Although female neurons were more advanced than male neu-
rons in the development of some morphological characteristics,
such as the growth and elongation of the axon and the branching
of neurites, this was not the case for other parameters analyzed.
Thus, the number of primary neurites per neuron, the length
of minor processes and the length of dendrites showed similar
values in male and female cultures under basal conditions. There-
fore, some parameters of the neuritogenic process are sexually
dimorphic and others are sex-independent.
Our ﬁndings have revealed a sex dimorphic expression of Ngn3
in hypothalamic neurons. Male neurons, which show a retarded
neuritic differentiation compared to female neurons, showed
decreased mRNA levels of the neuritogenic factor Ngn3. Given
the effect of Ngn3 on neuritogenesis and neuronal differentiation,
our ﬁndings suggest that the sex differences in Ngn3 expression
may be the cause of the sex differences in neuronal maturation.
To test this hypothesis we used a Ngn3 siRNA that was previ-
ously shown to reduce Ngn3 levels in neurons (Ruiz-Palmero
et al., 2011). The Ngn3 siRNA decreased Ngn3 expression with
the same efﬁcacy in male and female neurons. However, the Ngn3
siRNA showed morphological effects in female neurons but not
in male neurons. Thus, Ngn3 siRNA decreased neuronal matu-
ration, the length of the axon and the proportion of cells with
branched neurites in female cultures, but not in male cultures.
The ﬁnal result was that female neurons treated with the Ngn3
siRNA showed similar developmental characteristics than male
neurons. Interestingly, the developmental effects of Ngn3 siRNA
were restricted to those parameters that showed sex differences.
Thus, Ngn3 siRNA did not affect the length of minor processes or
the length of dendrites. These ﬁndings indicate that the differen-
tial expression of Ngn3 mediates sex differences in some speciﬁc
morphological parameters during neuronal development. Further
studies are necessary to determine whether these observations
reﬂect in vivo phenomena of embryonic hypothalamic neurons.
The limited data available indicates that Ngn3 is expressed in
the hypothalamic regions of mouse embryos from E9.5 to E17.5
(Pelling et al., 2011).
To determine whether sex differences in Ngn3 expression in
hypothalamic neurons was depending on hormones derived from
the gonads at or before E14, we analyzed Ngn3 mRNA levels in
hypothalamic neurons originated from XY male vs. XY female,
and XX male vs. XX female mouse embryos. No sex differences
were found in cultures from embryos with same sex chromo-
some complement and different gonadal phenotype, indicating
that there would not be gonadal hormone effects on the Ngn3
expression in the hypothalamus at this age. On the contrary,
our ﬁndings indicate that sex chromosome complement deter-
mines sex differences in Ngn3 expression: cells carrying different
sex chromosome gene(s) showed different Ngn3 mRNA levels
(XY < XX). Thus, sex differences in the expression of the auto-
somal Ngn3 gene should be the consequence of differences in
the expression of X or Y chromosome genes that result from the
inherent sex difference in the number (two copies of X) and/or
type (presence or absence of Y) of sex chromosomes. There-
fore, our study has identiﬁed a gene, Ngn3, which mediates
cell-autonomous actions of sex chromosomes in the generation
of sex differences in neuronal development. Additional studies are
necessary to ﬁnd the primary sex chromosome sex-determining
gene(s) responsible to activate downstream pathways that dif-
ferently regulate Ngn3 expression in males and females. Several
X/Y-linked genes encoding transcriptional regulator proteins have
the potential to mediate chromatin changes and regulate autoso-
mal gene expression (Wijchers and Festenstein, 2011). Sry gene
in the Y chromosome, which induces testicular differentiation,
can be excluded as a potential candidate for generating this sex
difference since XX vs. XY difference in Ngn3 expression was
found irrespective of the presence or absence of this gene. Some
genes in the X chromosome, such as Kdm6a and Kdm5c (also
known as Smcx or Jarid1c), which escape X-inactivation (Reinius
et al., 2010; Yang et al., 2010), encode histone demethylases and
show higher expression in 2× mice compare to 1× for both sexes
(Xu et al., 2002) before and after gonadal differentiation (Wolsten-
holme et al., 2013). Interestingly, studies in primary mammalian
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neurons demonstrated a role for Kdm5c in neuritic development
(Iwase et al., 2007).
In addition to Ngn3, other genes might be involved in sex
chromosome-mediated induction of sex differences in neuronal
development. Studies on gene proﬁling revealed a number of
autosomal genes differentially expressed between the sexes and
in mice with different number of X chromosomes. Among them,
Nptx2, Nedd9, Rorb, Cux2, and Htr3a are involved in neuronal
development or associated with neurological diseases (Wolsten-
holme et al., 2013). Cux2 (cut-like homeobox 2 gene) regulates
fundamental aspects of late neuronal differentiation and controls
intrinsic mechanisms of dendrite development, spine formation
and synaptic function in layers II–III of the cortex (Cubelos
et al., 2010). Cux2 has been identiﬁed as upstream and down-
stream target of Notch signaling (Iulianella et al., 2009; Wittmann
et al., 2014) and Cux2 overexpression has been shown to inhibit
Notch signaling in the olfactory epithelium (Wittmann et al.,
2014). This is relevant for our ﬁndings, since Ngn3 transcrip-
tion is negatively regulated by Notch signaling (Salama-Cohen
et al., 2006). Whether Cux2 regulates Notch/Ngn3 signaling
during neuritogenesis in hypothalamic neurons remains to be
determined.
The enhanced differentiation of female hypothalamic neurons
observed in our study is in apparent contradiction with the fact
that, in general, male neurons in the ventromedial hypothala-
mus and preoptic area have longer dendrites, increased dendritic
surface and more synaptic contacts than female neurons (Ayoub
et al., 1983; Matsumoto and Arai, 1986; Madeira et al., 1999; Grif-
ﬁn and Flanagan-Cato, 2009; Flanagan-Cato, 2011). A possible
interpretation is that what we have observed in our cultures
is the process of neuronal differentiation before the peak of
testosterone production by fetal testis. Interestingly, in hypotha-
lamic cultures obtained from E19 rat embryos (i.e., during the
peak of fetal testosterone that in rats is on fetal days 18.5–19.5;
Huhtaniemi, 1994; Scott et al., 2009), male hypothalamic neu-
rons differentiate axons earlier and have more primary neurites
and longer dendrites than female neurons (Díaz et al., 1992).
Therefore, based on these previous studies and on our present
ﬁndings, it may be postulated that female neurons are pro-
grammed by sex chromosomes for a faster development than
male neurons. However, fetal testosterone, after its intracere-
bral conversion to estradiol (Naftolin et al., 1972; Zwain and
Yen, 1999; Hojo et al., 2004), would reprogram male hypotha-
lamic neurons for an enhanced neuronal differentiation. In this
regard, it is interesting to note that in cultures from ventro-
medial hypothalamus of rat fetuses at E16, only neurons from
males respond with increased axonal growth to the addition of
estradiol to the culture medium (Cambiasso et al., 1995, 2000).
Our present ﬁndings conﬁrm this previous observation, show-
ing that estradiol enhanced neuronal differentiation and increased
axonal length and the proportion of neurons with branched
neurites only in male neurons. The effect of estradiol resulted
in the abolishment of the sex differences in the morphologi-
cal stages of maturation and in the reversion of sex differences
in axonal length and the proportion of neurons with branched
neurites. This suggests that before the peak of fetal testosterone,
male hypothalamic neurons show a slower development but are
more sensitive to estradiol than female neurons. This enhanced
sensitivity to estradiol in male neurons may facilitate the genera-
tion of sex differences after the peak of testosterone production
by fetal testis. Interestingly, recent studies have shown that
estradiol promotes neuritogenesis by the upregulation of Ngn3
(Ruiz-Palmero et al., 2011). Indeed, the knockdown of Ngn3
expression in primary neuronal cultures using a small inter-
ference RNA blocks the effects of estradiol on neuritogenesis,
indicating that Ngn3 mediates the action of estradiol on neurito-
genesis (Ruiz-Palmero et al., 2011). Our present ﬁndings, showing
that estradiol increases neuritogenesis in male neurons in par-
allel with an increase in Ngn3 mRNA levels, suggest that Ngn3
may be crucial for determining not only cell-autonomous actions
of sex chromosomes but also hormonal inﬂuences on neuronal
differentiation.
In summary, we have identiﬁed an autosomal gene that medi-
ates cell-autonomous actions of sex chromosomes on the gener-
ation of sex differences in neuronal development. Our ﬁndings
suggest that sex chromosomes enhance female neuronal differen-
tiation by the upregulation of Ngn3. In addition, by maintaining
a reduced expression of Ngn3 in male neurons, sex chromosomes
may contribute to provide these neuronswith an increased respon-
siveness to estradiol, facilitating the neuritogenic action of the
hormone through the upregulation of Ngn3.
AUTHOR CONTRIBUTIONS
Conceived and designed the experiments: María J. Scerbo, Maria
A. Arevalo, Luis M. Garcia-Segura,María J. Cambiasso. Performed
the experiments: María J. Scerbo, Alejandra Freire-Regatillo, Carla
D.Cisternas. Analyzed the data:María J. Scerbo,CarlaD.Cisternas,
María J. Cambiasso. Statistical analysis: Mabel Brunotto, María
J. Cambiasso. Wrote the paper: Luis M. Garcia-Segura, María J.
Cambiasso. Edited the manuscript and helped with the outline of
the paper: María J. Scerbo, Maria A. Arevalo.
ACKNOWLEDGMENTS
This study was supported by grants from CONICET (PIP 2010–
2012), ANPCyT (PICT 2008 No. 0456), MinCyT-Córdoba and
SECyT-UNC, Argentina to María J. Cambiasso and from Ministe-
rio de Economía y Competividad, Spain (BFU2011–30217-C03–
01) to Luis M. Garcia-Segura and Maria A. Arevalo. We would
like to thank to all the institutions and research associations that
made possible the travels and work of María J. Scerbo at the
Instituto Cajal, Madrid, Spain: “Short Term Travel Grant from
the International Brain Research Organization (IBRO),” “Wood-
Whelan Research Fellowships from the International Union of
Biochemistry and Molecular Biology (IUBMB),” “Programas de
Pasantías en el Extranjero de Becarios Post Doctorales del Consejo
Nacional de Investigaciones Cientíﬁcas y Técnicas (CONICET) de
la Republica Argentina,” “Category 1A Grant from the Commit-
tee for Aid and Education in Neurochemistry of the International
Society for Neurochemistry (CAEN-ISN),” and“Traveling Fellow-
ship from The Company of Biologists’ Journals (Development,
Disease Models & Mechanisms).” María J. Cambiasso is grateful
toDr. Paul Burgoyne (Medical ResearchCouncilNational Institute
for Medical Research, London, UK) for providing the transgenic
mice.
Frontiers in Cellular Neuroscience www.frontiersin.org July 2014 | Volume 8 | Article 188 | 11
Scerbo et al. Ngn3-induced sex differences in the hypothalamus
REFERENCES
Arnold, A. P., and Burgoyne, P. S. (2004). Are XX and XY brain cells intrinsically
different? Trends Endocrinol. Metab. 15, 6–11. doi: 10.1016/j.tem.2003.11.001
Arnold, A. P., and Chen, X. (2009). What does the “four core genotypes” mouse
model tell us about sex differences in the brain and other tissues? Front.
Neuroendocrinol. 30:1–9. doi: 10.1016/j.yfrne.2008.11.001
Arnold, A. P., Chen, X., Link, J. C., Itoh, Y., and Reue, K. (2013). Cell-
autonomous sex determination outside of the gonad. Dev. Dyn. 242, 371–379.
doi: 10.1002/dvdy.23936
Arnold, A. P., and Gorski, R. A. (1984). Gonadal steroid induction of structural sex
differences in the central nervous system. Annu. Rev. Neurosci. 7, 413–442. doi:
10.1146/annurev.ne.07.030184.002213
Ayoub, D. M., Greenough, W. T., and Juraska, J. M. (1983). Sex differences in
dendritic structure in the preoptic area of the juvenile macaque monkey brain.
Science 219, 197–198. doi: 10.1126/science.6849133
Beyer, C., Epp, B., Fassberg, J., Reisert, I., and Pilgrim, C. (1990). Region- and
sex-related differences in maturation of astrocytes in dissociated cell cultures of
embryonic rat brain. Glia 3, 55–64. doi: 10.1002/glia.440030108
Beyer, C., Kolbinger, W., Froehlich, U., Pilgrim, C., and Reisert, I. (1992). Sex
differences of hypothalamic prolactin cells develop independently of the pres-
ence of sex steroids. Brain Res. 593, 253–256. doi: 10.1016/0006-8993(92)
91315-6
Caeiro, X. E., Mir, F. R., Vivas, L. M., Carrer, H. F., and Cambiasso, M. J. (2011).
Sex chromosome complement contributes to sex differences in bradycardic
baroreﬂex response. Hypertension 58, 505–511. doi: 10.1161/HYPERTENSION-
AHA.111.175661
Cambiasso, M. J., Colombo, J. A., and Carrer, H. F. (2000). Differential effect
of oestradiol and astroglia-conditioned media on the growth of hypothalamic
neurons from male and female rat brains. Eur. J. Neurosci. 12, 2291–2298. doi:
10.1046/j.1460-9568.2000.00120.x
Cambiasso, M. J., Díaz, H., Cáceres, A., and Carrer, H. F. (1995). Neurito-
genic effect of estradiol on rat ventromedial hypothalamic neurons co-cultured
with homotopic or heterotopic glia. J. Neurosci. Res. 42, 700–709. doi:
10.1002/jnr.490420513
Carruth, L. L., Reisert, I., and Arnold, A. P. (2002). Sex chromosome genes directly
affect brain sexual differentiation. Nat. Neurosci. 5, 933–934. doi: 10.1038/nn922
Cubelos, B., Sebastián-Serrano,A., Beccari, L., Calcagnotto,M. E., Cisneros, E., Kim,
S., et al. (2010). Cux1 and Cux2 regulate dendritic branching, spine morphology,
and synapses of the upper layer neurons of the cortex. Neuron 66, 523–535. doi:
10.1016/j.neuron.2010.04.038
Dadam, F. M., Caeiro, X. E., Cisternas, C. D., Macchione, A. F., Cambiasso, M. J.,
and Vivas, L. (2014). Effect of sex chromosome complement on sodium appetite
and Fos-immunoreactivity induced by sodium depletion. Am. J. Physiol. Regul.
Integr. Comp. Physiol. 306, R175–R184. doi: 10.1152/ajpregu.00447.2013
Davies, W., Isles, A. R., Burgoyne, P. S., and Wilkinson, L. S. (2006).
X-linked imprinting: effects on brain and behaviour. Bioessays 28, 35–44. doi:
10.1002/bies.20341
DeVries, G. J., Rissman, E. F., Simerly, R. B.,Yang, L.-Y., Scordalakes, E. M.,Auger, C.
J., et al. (2002). A model system for study of sex chromosome effects on sexually
dimorphic neural and behavioral traits. J. Neurosci. 22, 9005–9014.
Díaz, H., Lorenzo, A., Carrer, H. F., and Cáceres, A. (1992). Time lapse study
of neurite growth in hypothalamic dissociated neurons in culture: sex differ-
ences and estrogen effects. J. Neurosci. Res. 33, 266–281. doi: 10.1002/jnr.4903
30210
Dotti, C. G., Sullivan, C. A., and Banker, G. A. (1988). The establishment of polarity
by hippocampal neurons in culture. J. Neurosci. 8, 1454–1468.
Engele, J., Pilgrim, C., and Reisert, I. (1989). Sexual differentiation of mesencephalic
neurons in vitro: effects of sex and gonadal hormones. Int. J. Dev. Neurosci. 7,
603–611. doi: 10.1016/0736-5748(89)90019-1
Ferreira, A., and Caceres, A. (1991). Estrogen-enhanced neurite growth: evidence
for a selective induction of Tau and stable microtubules. J. Neurosci. 11, 392–400.
Flanagan-Cato, L. M. (2011). Sex differences in the neural circuit that medi-
ates female sexual receptivity. Front. Neuroendocrinol. 32:124–136. doi:
10.1016/j.yfrne.2011.02.008
Gatewood, J. D.,Wills,A., Shetty, S., Xu, J.,Arnold,A. P., Burgoyne, P. S., et al. (2006).
Sex chromosome complement and gonadal sex inﬂuence aggressive and parental
behaviors in mice. J. Neurosci. 26, 2335–2342. doi: 10.1523/JNEUROSCI.3743-
05.2006
Gioiosa, L., Chen, X., Watkins, R., Klanfer, N., Bryant, C. D., Evans, C. J.,
et al. (2008). Sex chromosome complement affects nociception in tests of acute
and chronic exposure to morphine in mice. Horm. Behav. 53, 124–130. doi:
10.1016/j.yhbeh.2007.09.003
Grifﬁn,G.D., andFlanagan-Cato, L.M. (2009). Sexdifferences in the dendritic arbor
of hypothalamic ventromedial nucleus neurons. Physiol. Behav. 97, 151–156. doi:
10.1016/j.physbeh.2009.02.019
Gubbay, J., Collignon, J., Koopman, P., Capel, B., Economou, A., Münsterberg,
A., et al. (1990). A gene mapping to the sex-determining region of the mouse Y
chromosome is a member of a novel family of embryonically expressed genes.
Nature 346, 245–250. doi: 10.1038/346245a0
Hojo, Y., Hattori, T.-A., Enami, T., Furukawa, A., Suzuki, K., Ishii, H.-T., et al.
(2004). Adult male rat hippocampus synthesizes estradiol from pregnenolone by
cytochromes P45017alpha and P450 aromatase localized in neurons. Proc. Natl.
Acad. Sci. U.S.A. 101, 865–870. doi: 10.1073/pnas.2630225100
Huhtaniemi, I. (1994). Fetal testis–a very special endocrine organ. Eur. J. Endocrinol.
130, 25–31. doi: 10.1530/eje.0.1300025
Iulianella, A., Sharma, M., Vanden Heuvel, G. B., and Trainor, P. A. (2009).
Cux2 functions downstream of Notch signaling to regulate dorsal interneuron
formation in the spinal cord. Development 136, 2329–2334. doi: 10.1242/dev.
032128
Iwase, S., Lan, F., Bayliss, P., de la Torre-Ubieta, L.,Huarte,M.,Qi,H.H., et al. (2007).
TheX-linkedmental retardation gene SMCX/JARID1C deﬁnes a family of histone
H3 lysine 4 demethylases. Cell 128, 1077–1088. doi: 10.1016/j.cell.2007.02.017
Kopsida, E., Stergiakouli, E., Lynn, P.M.,Wilkinson, L. S., andDavies,W. (2009). The
role of the Y chromosome in brain function. Open Neuroendocrinol. J. 2, 20–30.
doi: 10.2174/1876528900902010020
Lenz, K. M., and McCarthy, M. M. (2010). Organized for sex-steroid hor-
mones and the developing hypothalamus. Eur. J. Neurosci. 32, 2096–2104. doi:
10.1111/j.1460-9568.2010.07511.x
Livak, K. J., and Schmittgen, T. D. (2001). Analysis of relative gene expression data
using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods
25, 402–408. doi: 10.1006/meth.2001.1262
Lovell-Badge, R., and Robertson, E. (1990). XY female mice resulting from a her-
itable mutation in the primary testis-determining gene, Tdy. Development 109,
635–646.
MacLusky,N. J., andNaftolin, F. (1981). Sexual differentiation of the central nervous
system. Science 211, 1294–1302. doi: 10.1126/science.6163211
Madeira, M. D., Leal, S., and Paula-Barbosa, M. M. (1999). Stereological evaluation
and Golgi study of the sexual dimorphisms in the volume, cell numbers, and cell
size in the medial preoptic nucleus of the rat. J. Neurocytol. 28, 131–148. doi:
10.1023/A:1007076206828
Mahadevaiah, S. K., Odorisio, T., Elliott, D. J., Rattigan, Á., Szot, M., Laval, S.
H., et al. (1998). Mouse homologues of the human AZF candidate gene RBM
are expressed in spermatogonia and spermatids, and map to a Y chromosome
deletion interval associated with a high incidence of sperm abnormalities. Hum.
Mol. Genet. 7, 715–727. doi: 10.1093/hmg/7.4.715
Matsumoto,A., andArai,Y. (1986). Male–female difference in synaptic organization
of the ventromedial nucleus of the hypothalamus in the rat. Neuroendocrinology
42, 232–236. doi: 10.1159/000124445
Naftolin, F., Ryan, K. J., and Petro, Z. (1972). Aromatization of androstenedione
by the anterior hypothalamus of adult male and female rats. Endocrinology 90,
295–298. doi: 10.1210/endo-90-1-295
O’Shaughnessy, P. J., Baker, P. J., and Johnston, H. (2006). The foetal Leydig cell–
differentiation, function and regulation. Int. J. Androl. 29, 90–95; discussion
105–108. doi: 10.1111/j.1365-2605.2005.00555.x
O’Shaughnessy, P. J., Baker, P., Sohnius, U., Haavisto, A. M., Charlton, H. M., and
Huhtaniemi, I. (1998). Fetal development of Leydig cell activity in the mouse is
independent of pituitary gonadotroph function. Endocrinology 139, 1141–1146.
doi: 10.1210/en.139.3.1141
Palaszynski, K. M., Smith, D. L., Kamrava, S., Burgoyne, P. S., Arnold, A. P., and
Voskuhl, R. R. (2005). A yin-yang effect between sex chromosome complement
and sex hormones on the immune response. Endocrinology 146, 3280–3285. doi:
10.1210/en.2005-0284
Pelling, M., Anthwal, N., McNay, D., Gradwohl, G., Leiter, A. B., Guillemot, F.,
et al. (2011). Differential requirements for neurogenin 3 in the development of
POMC and NPY neurons in the hypothalamus. Dev. Biol. 349, 406–416. doi:
10.1016/j.ydbio.2010.11.007
Frontiers in Cellular Neuroscience www.frontiersin.org July 2014 | Volume 8 | Article 188 | 12
Scerbo et al. Ngn3-induced sex differences in the hypothalamus
Phoenix, C. H., Goy, R. W., Gerall, A. A., and Young, W. C. (1959). Organizing
action of prenatally administered testosterone propionate on the tissues mediat-
ing mating behavior in the female guinea pig. Endocrinology 65, 369–382. doi:
10.1210/endo-65-3-369
Quinn, J. J., Hitchcott, P. K., Umeda, E. A., Arnold, A. P., and Taylor, J. R. (2007). Sex
chromosome complement regulates habit formation. Nat. Neurosci. 10, 1398–
1400. doi: 10.1038/nn1994
Reinius, B., Shi, C., Hengshuo, L., Sandhu, K. S., Radomska, K. J., Rosen, G. D.,
et al. (2010). Female-biased expression of long non-coding RNAs in domains
that escape X-inactivation in mouse. BMC Genomics 11:614. doi: 10.1186/1471-
2164-11-614
Reisert, I., Engele, J., and Pilgrim, C. (1989). Early sexual differentiation of dien-
cephalic dopaminergic neurons of the rat in vitro. Cell Tissue Res. 255, 411–417.
doi: 10.1007/BF00224125
Reisert, I., and Pilgrim, C. (1991). Sexual differentiation of monoaminergic
neurons–genetic or epigenetic? Trends Neurosci. 14, 468–473. doi: 10.1016/0166-
2236(91)90047-X
Ruiz-Palmero, I., Simon-Areces, J., Garcia-Segura, L. M., andArevalo,M.-A. (2011).
Notch/neurogenin 3 signalling is involved in the neuritogenic actions of oestra-
diol in developing hippocampal neurones. J. Neuroendocrinol. 23, 355–364. doi:
10.1111/j.1365-2826.2011.02110.x
Salama-Cohen, P., Arévalo, M.-A., Grantyn, R., and Rodríguez-Tébar, A. (2006).
Notch and NGF/p75NTR control dendrite morphology and the balance of
excitatory/inhibitory synaptic input to hippocampal neurones through Neu-
rogenin 3. J. Neurochem. 97, 1269–1278. doi: 10.1111/j.1471-4159.2006.
03783.x
Scott, H. M., Mason, J. I., and Sharpe, R. M. (2009). Steroidogenesis in the fetal
testis and its susceptibility to disruption by exogenous compounds. Endocr. Rev.
30, 883–925. doi: 10.1210/er.2009-2016
Semaan, S. J., and Kauffman, A. S. (2010). Sexual differentiation and develop-
ment of forebrain reproductive circuits. Curr. Opin. Neurobiol. 20, 424–431. doi:
10.1016/j.conb.2010.04.004
Simon-Areces, J., Membrive, G., Garcia-Fernandez, C., Garcia-Segura, L. M., and
Arevalo, M.-A. (2010). Neurogenin 3 cellular and subcellular localization in
the developing and adult hippocampus. J. Comp. Neurol. 518, 1814–1824. doi:
10.1002/cne.22304
Smith-Bouvier, D. L., Divekar, A. A., Sasidhar, M., Du, S., Tiwari-Woodruff, S. K.,
King, J. K., et al. (2008). A role for sex chromosome complement in the female
bias in autoimmune disease. J. Exp. Med. 205, 1099–1108. doi: 10.1084/jem.
20070850
Turner, J. M., Mahadevaiah, S. K., Benavente, R., Offenberg, H. H., Heyting, C.,
and Burgoyne, P. S. (2000). Analysis of male meiotic “sex body” proteins during
XY female meiosis provides new insights into their functions. Chromosoma 109,
426–432. doi: 10.1007/s004120000097
Wijchers, P. J., and Festenstein, R. J. (2011). Epigenetic regulation of autoso-
mal gene expression by sex chromosomes. Trends Genet. 27, 132–140. doi:
10.1016/j.tig.2011.01.004
Wittmann,W., Iulianella,A., andGunhaga, L. (2014). Cux2 acts as a critical regulator
for neurogenesis in the olfactory epithelium of vertebrates. Dev. Biol. 388, 35–47.
doi: 10.1016/j.ydbio.2014.01.026
Wolstenholme, J. T., Rissman, E. F., and Bekiranov, S. (2013). Sexual differentiation
in the developing mouse brain: contributions of sex chromosome genes. Genes
Brain Behav. 12, 166–180. doi: 10.1111/gbb.12010
Xu, J., Burgoyne, P. S., and Arnold, A. P. (2002). Sex differences in sex chromo-
some gene expression in mouse brain. Hum. Mol. Genet. 11, 1409–1419. doi:
10.1093/hmg/11.12.1409
Yang, F., Babak, T., Shendure, J., and Disteche, C. M. (2010). Global survey of escape
from X inactivation by RNA-sequencing in mouse. Genome Res. 20, 614–622. doi:
10.1101/gr.103200.109
Zwain, I. H., and Yen, S. S. (1999). Neurosteroidogenesis in astrocytes, oligodendro-
cytes, and neurons of cerebral cortex of rat brain. Endocrinology 140, 3843–3852.
doi: 10.1210/endo.140.8.6907
Conflict of Interest Statement:The authors declare that the researchwas conducted
in the absence of any commercial or ﬁnancial relationships that could be construed
as a potential conﬂict of interest.
Received: 02 May 2014; accepted: 19 June 2014; published online: 08 July 2014.
Citation: Scerbo MJ, Freire-Regatillo A, Cisternas CD, Brunotto M, Arevalo MA,
Garcia-Segura LM and Cambiasso MJ (2014) Neurogenin 3 mediates sex chromo-
some effects on the generation of sex differences in hypothalamic neuronal development.
Front. Cell. Neurosci. 8:188. doi: 10.3389/fncel.2014.00188
This article was submitted to the journal Frontiers in Cellular Neuroscience.
Copyright© 2014 Scerbo, Freire-Regatillo, Cisternas, Brunotto, Arevalo, Garcia-Segura
andCambiasso. This is an open-access article distributed under the terms of theCreative
Commons Attribution License (CC BY). The use, distribution or reproduction in other
forums is permitted, provided the original author(s) or licensor are credited and that
the original publication in this journal is cited, in accordance with accepted academic
practice. No use, distribution or reproduction is permitted which does not comply with
these terms.
Frontiers in Cellular Neuroscience www.frontiersin.org July 2014 | Volume 8 | Article 188 | 13
